Center For Financial Planning, Inc. Amgen Inc Transaction History

Center For Financial Planning, Inc.

$748 Million
Q4 2024

A detailed history of Center For Financial Planning, Inc. transactions in Amgen Inc stock. As of the latest transaction made, Center For Financial Planning, Inc. holds 750 shares of AMGN stock, worth $236,722. This represents 0.03% of its overall portfolio holdings.

Number of Shares

750

Previous 750 -0.0%

Holding current value

$236,722

Previous $241,000 19.09%

% of portfolio

0.03%

Previous 0.03%

13 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 15, 2024	SELL	$309.38 - $337.38 $16,087 - $17,543	-52 Reduced 6.48%	750 $241,000
Q2 2024 Jul 18, 2024	SELL	$262.75 - $319.31 $12,874 - $15,646	-49 Reduced 5.76%	802 $250,000
Q1 2024 Apr 25, 2024	BUY	$268.87 - $324.56 $13,174 - $15,903	49 Added 6.11%	851 $241,000
Q4 2023 Jan 29, 2024	BUY	$255.7 - $288.46 $13,296 - $14,999	52 Added 6.93%	802 $230,000
Q1 2022 May 03, 2022	SELL	$219.27 - $242.57 $6,578 - $7,277	-30 Reduced 3.85%	750 $181,000
Q3 2021 Oct 27, 2021	SELL	$212.27 - $248.7 $165,146 - $193,488	-778 Reduced 49.94%	780 $166,000
Q2 2021 Jul 29, 2021	SELL	$233.58 - $259.14 $10,277 - $11,402	-44 Reduced 2.75%	1,558 $380,000
Q1 2021 May 10, 2021	BUY	$221.91 - $258.6 $29,070 - $33,876	131 Added 8.91%	1,602 $399,000
Q4 2020 Feb 09, 2021	BUY	$216.38 - $257.67 $17,310 - $20,613	80 Added 5.75%	1,471 $338,000
Q3 2020 Nov 12, 2020	BUY	$234.65 - $260.95 $5,631 - $6,262	24 Added 1.76%	1,391 $354,000
Q2 2020 Aug 06, 2020	BUY	$197.81 - $242.74 $113,542 - $139,332	574 Added 72.38%	1,367 $322,000
Q1 2020 May 11, 2020	BUY	$182.24 - $241.7 $7,836 - $10,393	43 Added 5.73%	793 $161,000
Q4 2019 Feb 14, 2020	BUY	$189.21 - $243.2 $141,907 - $182,400	750 New	750 $181,000

Others Institutions Holding AMGN

# of Institutions

3,167

Shares Held

418M

Call Options Held

8.25M

Put Options Held

6.39M

View Full List

About AMGEN INC

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $169B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

More about AMGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Center For Financial Planning, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Center For Financial Planning, Inc. with notifications on news.

Account

Center For Financial Planning, Inc. Amgen Inc Transaction History